Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-25 @ 5:19 AM
NCT ID:
NCT01412827
Eligibility Criteria:
Inclusion Criteria:
* Consecutive patients presenting for clinically indicated SPECT perfusion scan
* Patients presenting to sites with a functional CZT camera. Available sites are Ottawa (OHI), Mississauga, and Calgary.
* Age \>18 years old
Exclusion Criteria:
* Patients with a life expectancy less than 1 year, from non cardiac cause
* Age \< 18 years old or lack of consent
* Allergy or contraindication to dipyridamole
* Refractory angina or infarction or need for urgent angiography
* Known pregnancy
* Uncontrolled atrial fibrillation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01412827
Study Brief:
Protocol Section:
NCT01412827